Sandbox29: Difference between revisions

(2 intermediate revisions by the same user not shown)

Line 6:

Created by Lori Mathis

1eve is a protein that is a drug used to prevent Alzheimer disease. The <scene name='Sandbox29/1eve/1'>overall structure</scene> of 1EVE contains a <scene name='Sandbox29/Evebeta/1'>beta ~~sheet~~</scene> ~~section with 15 sheets~~ and 16 <scene name='Sandbox29/Evealpha/1'>alpha helices</scene>. 1eve is a fairly standard molecule in the sense that the

1eve is a protein that is a drug used to prevent Alzheimer disease. The <scene name='Sandbox29/1eve/1'>overall structure</scene> of 1EVE contains 2 types of amphipathic elements; 15 <scene name='Sandbox29/Evebeta/1'>beta sheets</scene> and 16 <scene name='Sandbox29/Evealpha/1'>alpha helices</scene>. 1eve is a fairly standard molecule in the sense that the

<scene name='Sandbox29/Hydrophobic/1'>hydrophic</scene> aspects of the protein are well-maintained on the inside, while the hydrophillic portions are around the outside. 1eve has an active name called Acetylcholinesterase, which has a ligand called Aricept. 1eve is considered an AChE inhibitor, in which it has a high affinity for. The overall protein itself was created by a Japanese corporation called the Eisai Company.

<scene name='Sandbox29/Hydrophobic/1'>hydrophic</scene> aspects of the protein are well-maintained on the inside, while the hydrophillic portions are around the outside. 1eve has an active name called Acetylcholinesterase, which has a ligand called Aricept. There is an

<scene name='Sandbox29/Active_site/1'>active site</scene> in the middle of the molecule. 1eve is considered an AChE inhibitor, in which it has a high affinity for. The overall protein itself was created by a Japanese corporation called the Eisai Company.

Reference to the Proteopedia pages dedicated to 1EVE, contributors are Eran Hodis, Joel L. Sussman, OCA, Wayne Decatur

Sandbox29: Difference between revisions

Navigation menu

Page actions

Page actions

Personal tools

Navigation

Search

Tools

@@ Line 6: / Line 6: @@
 Created by Lori Mathis
-eve is a protein that is a drug used to prevent Alzheimer disease. The <scene name='Sandbox29/1eve/1'>overall structure</scene> of 1EVE contains a <scene name='Sandbox29/Evebeta/1'>beta sheet</scene> section with 15 sheets and 16 <scene name='Sandbox29/Evealpha/1'>alpha helices</scene>.  1eve is a fairly standard molecule in the sense that the
+eve is a protein that is a drug used to prevent Alzheimer disease. The <scene name='Sandbox29/1eve/1'>overall structure</scene> of 1EVE contains 2 types of amphipathic elements; 15 <scene name='Sandbox29/Evebeta/1'>beta sheets</scene> and 16 <scene name='Sandbox29/Evealpha/1'>alpha helices</scene>.  1eve is a fairly standard molecule in the sense that the
-<scene name='Sandbox29/Hydrophobic/1'>hydrophic</scene> aspects of the protein are well-maintained on the inside, while the hydrophillic portions are around the outside. 1eve has an active name called Acetylcholinesterase, which has a ligand called Aricept. 1eve is considered an AChE inhibitor, in which it has a high affinity for. The overall protein itself was created by a Japanese corporation called the Eisai Company.
+<scene name='Sandbox29/Hydrophobic/1'>hydrophic</scene> aspects of the protein are well-maintained on the inside, while the hydrophillic portions are around the outside. 1eve has an active name called Acetylcholinesterase, which has a ligand called Aricept. There is an
+<scene name='Sandbox29/Active_site/1'>active site</scene> in the middle of the molecule.  1eve is considered an AChE inhibitor, in which it has a high affinity for. The overall protein itself was created by a Japanese corporation called the Eisai Company.
 {{STRUCTURE_1eve |  PDB=1eve  |  SCENE=  }}
+Reference to the Proteopedia pages dedicated to 1EVE, contributors are Eran Hodis, Joel L. Sussman, OCA, Wayne Decatur